RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 122 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $632,034 | -4.6% | 585,217 | +13.9% | 0.00% | – |
| Q2 2023 | $662,590 | +1.9% | 513,635 | +4.2% | 0.00% | – |
| Q1 2023 | $650,535 | +6.9% | 492,829 | +21.4% | 0.00% | – |
| Q4 2022 | $608,813 | -78.7% | 405,875 | -83.3% | 0.00% | -100.0% |
| Q3 2022 | $2,860,000 | +30.6% | 2,423,908 | +25.1% | 0.00% | – |
| Q2 2022 | $2,190,000 | +16.9% | 1,937,924 | +209.2% | 0.00% | – |
| Q1 2022 | $1,874,000 | -60.3% | 626,670 | -64.9% | 0.00% | -100.0% |
| Q4 2021 | $4,726,000 | -44.7% | 1,783,320 | -24.2% | 0.00% | -50.0% |
| Q3 2021 | $8,543,000 | -0.8% | 2,353,287 | +18.6% | 0.00% | 0.0% |
| Q2 2021 | $8,608,000 | +56.5% | 1,983,422 | +23.3% | 0.00% | +100.0% |
| Q1 2021 | $5,501,000 | -45.9% | 1,608,552 | -44.6% | 0.00% | -66.7% |
| Q4 2020 | $10,165,000 | +354.2% | 2,904,420 | +211.4% | 0.00% | +200.0% |
| Q3 2020 | $2,238,000 | +274.2% | 932,736 | +185.5% | 0.00% | – |
| Q2 2020 | $598,000 | -82.8% | 326,750 | -85.3% | 0.00% | -100.0% |
| Q1 2020 | $3,472,000 | -47.9% | 2,225,802 | -28.5% | 0.00% | -50.0% |
| Q4 2019 | $6,664,000 | +22.8% | 3,114,076 | +7.3% | 0.00% | 0.0% |
| Q3 2019 | $5,425,000 | -3.3% | 2,901,212 | +35.0% | 0.00% | 0.0% |
| Q2 2019 | $5,610,000 | -0.3% | 2,149,449 | -1.8% | 0.00% | 0.0% |
| Q1 2019 | $5,625,000 | -40.7% | 2,188,745 | -46.9% | 0.00% | -33.3% |
| Q4 2018 | $9,483,000 | +40.3% | 4,122,873 | +95.8% | 0.00% | +50.0% |
| Q3 2018 | $6,759,000 | +20.4% | 2,105,568 | +6.2% | 0.00% | 0.0% |
| Q2 2018 | $5,612,000 | +210.7% | 1,983,231 | +288.8% | 0.00% | – |
| Q1 2018 | $1,806,000 | -0.8% | 510,130 | +8.8% | 0.00% | – |
| Q4 2017 | $1,820,000 | +281.6% | 469,037 | +149.7% | 0.00% | – |
| Q3 2017 | $477,000 | -5.4% | 187,814 | +1.7% | 0.00% | – |
| Q2 2017 | $504,000 | -20.3% | 184,622 | -3.3% | 0.00% | – |
| Q1 2017 | $632,000 | -56.9% | 191,001 | -69.0% | 0.00% | – |
| Q4 2016 | $1,466,000 | -78.1% | 615,806 | -66.2% | 0.00% | -100.0% |
| Q3 2016 | $6,684,000 | +2617.1% | 1,821,194 | +1552.0% | 0.00% | – |
| Q2 2016 | $246,000 | +44.7% | 110,242 | +34.6% | 0.00% | – |
| Q1 2016 | $170,000 | -5.6% | 81,900 | +38.0% | 0.00% | – |
| Q4 2015 | $180,000 | +73.1% | 59,357 | +40.7% | 0.00% | – |
| Q3 2015 | $104,000 | -60.5% | 42,201 | -48.5% | 0.00% | – |
| Q2 2015 | $263,000 | -39.5% | 82,003 | -32.8% | 0.00% | – |
| Q1 2015 | $435,000 | -18.2% | 121,982 | -48.0% | 0.00% | – |
| Q4 2014 | $532,000 | +184.5% | 234,383 | +144.1% | 0.00% | – |
| Q3 2014 | $187,000 | -68.8% | 96,013 | -41.9% | 0.00% | – |
| Q2 2014 | $600,000 | -67.2% | 165,253 | -64.9% | 0.00% | – |
| Q1 2014 | $1,827,000 | +176.8% | 470,895 | +103.4% | 0.00% | – |
| Q4 2013 | $660,000 | -67.0% | 231,531 | -58.6% | 0.00% | – |
| Q3 2013 | $2,003,000 | -28.9% | 559,522 | -33.7% | 0.00% | -100.0% |
| Q2 2013 | $2,817,000 | +339.5% | 843,327 | +756.0% | 0.00% | – |
| Q4 2012 | $641,000 | -77.6% | 98,514 | -64.8% | 0.00% | -100.0% |
| Q3 2012 | $2,866,000 | +83.6% | 279,874 | +66.7% | 0.00% | +100.0% |
| Q2 2012 | $1,561,000 | +296.2% | 167,929 | +242.8% | 0.00% | – |
| Q1 2012 | $394,000 | – | 48,983 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 1,500,000 | $1,620,000 | 1.72% |
| Soleus Capital Management, L.P. | 14,803,015 | $15,987,256 | 1.48% |
| ARMISTICE CAPITAL, LLC | 17,136,000 | $18,506,880 | 0.28% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,228,126 | $1,326,376 | 0.24% |
| GSA CAPITAL PARTNERS LLP | 971,441 | $1,049 | 0.09% |
| NJ State Employees Deferred Compensation Plan | 200,000 | $216,000 | 0.03% |
| Providence Wealth Advisors, LLC | 27,500 | $29,013 | 0.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,151,765 | $1,243,906 | 0.03% |
| XTX Topco Ltd | 164,238 | $177,377 | 0.03% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 3,369,076 | $3,638,602 | 0.02% |